Industry Trend

Site Sections

Menu








© 2023. All Rights reserved.

Overview for RESMED

All Data per March 3, 2023

Industry:

Medical Instruments & Supplies

Last Close:

219.81 USD

Expected Dividend:

0.80 %

Payoffs per Year:

4.0
Business Summary
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Competitors View

Ordering

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

NZL		 1.15 1.73%
1.69%		 6.97% 2.16% 1.0 19.46
-9.41%		 35.82 19.2% 73.3 1.0

ESSILORLUXOTTICA

FRA		 1.07 1.09%
2.02%		 5.42% 1.27% 1.0 4.58
-7.66%		 18.99 14.25% 59.21 2.0

CARL ZEISS MEDITEC

GER		 1.04 1.13%
0.64%		 4.8% 1.28% 1.0 12.93
-12.88%		 23.39 13.38% 69.25 3.0

BECTON, DICKINSON

USA		 1.02 1.64%
1.6%		 2.83% 1.7% 1.0 5.82
-8.0%		 28.0 10.48% 43.95 4.0

RESMED

USA
 0.99 1.54%
0.8%		 3.29% 1.63% 0.5 29.02
-4.23%		 36.11 14.09% 61.03 5.0

SARTORIUS

GER		 1.06 0.76%
0.39%		 15.46% 1.41% 1.0 -inf
0.0%		 10.13 18.31% 22.12 6.0

GERRESHEIMER

GER		 1.14 1.45%
1.54%		 5.12% 1.67% 1.0 1.3
-20.7%		 18.7 1.63% 34.1 7.0

TERUMO

JPN		 0.91 1.58%
1.06%		 5.1% 1.81% 1.0 -inf
0.0%		 17.4 3.68% 63.4 8.0

BAXTER INTERNATIONAL

USA		 0.8 1.3%
2.78%		 2.99% 1.36% 0.5 10.92
-4.17%		 21.26 3.9% 27.08 9.0

OLYMPUS

JPN		 0.87 0.43%
1.37%		 0.0% 0.39% 1.0 2.82
-29.69%		 10.6 12.37% 33.39 10.0

DENTSPLY SIRONA

USA		 1.05 0.56%
1.29%		 3.2% 0.59% 1.0 0.16
-43.48%		 13.89 3.73% 54.69 11.0

COOPER INC

USA		 1.08 0.04%
0.02%		 nan% nan% 1.0 4.32
-17.21%		 0.47 -0.24% 72.26 nan

Information for RESMED

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 41.57 0.34 0.82
2013 47.08 0.84 1.78
2014 56.06 1.06 1.89
2015 53.69 1.16 2.16
2016 62.05 1.26 2.03
2017 84.69 1.36 1.61
2018 113.87 1.44 1.26
2019 154.97 1.52 0.98
2020 212.56 1.56 0.73
2021 260.48 1.62 0.62
2023 219.81 1.76 0.80

Fundamentals

Chart